share_log

Mangoceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

Mangoceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

Mangoceuticals | 144:擬議出售證券
美股SEC公告 ·  06/19 02:58

牛牛AI助理已提取核心訊息

Alex P. Hamilton, a member of the Board of Directors for Mangoceuticals, Inc., is set to sell 50,000 common shares of the company. The sale, with an aggregate market value of $15,000, is scheduled for 06/21/2024. These shares were originally acquired as pre-IPO shares from Mangoceuticals on 10/22/2022. The transaction history for the past three months does not report any other sales of securities by Hamilton.
Alex P. Hamilton, a member of the Board of Directors for Mangoceuticals, Inc., is set to sell 50,000 common shares of the company. The sale, with an aggregate market value of $15,000, is scheduled for 06/21/2024. These shares were originally acquired as pre-IPO shares from Mangoceuticals on 10/22/2022. The transaction history for the past three months does not report any other sales of securities by Hamilton.
董事會成員Alex P. Hamilton計劃賣出公司的5萬股普通股,市值達到15000美元。此次交易預計於2024年6月21日進行。這些股份最初於2022年10月22日從Mangoceuticals獲得。在過去三個月的交易記錄中,沒有其他證券的銷售記錄。
董事會成員Alex P. Hamilton計劃賣出公司的5萬股普通股,市值達到15000美元。此次交易預計於2024年6月21日進行。這些股份最初於2022年10月22日從Mangoceuticals獲得。在過去三個月的交易記錄中,沒有其他證券的銷售記錄。

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生,只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。